Keeping It Real: Reversing Effects of Anticoagulation in the Modern Era with Real World Data

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Keeping It Real: Reversing Effects of Anticoagulation in the Modern Era with Real World Data

8 episodes
1.50 program credits
1h 30m
ReachMD Healthcare Image
Choose a format
Take Program Post-Test
Program Post-Test Completed
1.50 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
  • Overview

    The introduction and assessment of real-world data (RWD) associated with FXa inhibitor-related bleeds is of critical importance in treatment-emergent situations, as there has been limited information disseminated to date within the relatively complex clinical landscape. This program focuses on the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant. It covers the most recent key RWD published relative to the use of reversal or repletion strategies in anticoagulated patients. 

  • Target Audience

    This activity has been designed to meet the educational needs of the interprofessional team, including hematology, vascular medicine, vascular surgery, pulmonology/critical care, neurology, gastroenterology, trauma, hospital medicine, emergency medicine, cardiology, and internal medicine, as well as other clinicians involved in the management of patients on anticoagulation with life-threatening bleeding.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to: 

    • Evaluate recent practice-changing data that can be applied to practice in the presence of a life-threatening bleed in the presence of anticoagulation
    • Apply the latest evidence-based approaches to maximize management prognostic outcomes for life-threatening bleeds 
  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

  • Faculty Disclosure of Commercial Relationships

    Disclosure Policy
    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs. 

    The following faculty have disclosed:

    Jan Beyer-Westendorf, MD, PhD, chair for this educational event, received research funding from Bayer, Boehringer Ingelheim, Daiichi Sankyo, Pfizer, and Alexion/AstraZeneca; and received consulting fees from Bayer, Daiichi Sankyo, DOASENSE, Norgine, Pfizer, Takeda, and Alexion/AstraZeneca. 

    Craig I. Coleman, PharmD, FASHP, faculty for this educational event,  research funding from Bayer AG, AstraZeneca Pharmaceuticals, and Janssen Scientific Affairs, LLC; and received consulting fees from Bayer AG, AstraZeneca Pharmaceuticals, and Janssen Scientific Affairs, LLC.

    Paul Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP, faculty for this educational event, received consulting fees from The Pfizer/BMS Alliance, AstraZeneca, and Janssen Pharmaceuticals.

    Deborah Siegal, MD, MSc, FRCPC, faculty for this educational event, has no relevant financial relationships with ineligible companies.

  • Planners and Managers Disclosure List

    The following planners/reviewers/managers have disclosed:

    William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.

    Tota CME, LLC. Planners and managers have no relevant commercial relationships to disclose.

    All the relevant financial relationships for these individuals have been mitigated.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and TotalCME, Inc. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go, you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Acknowledgment

    This activity is supported by an independent educational grant from AstraZeneca. 

    Jointly provided by Global Learning Collaborative (GLC) and Total CME, LLC.

  • Instructions for Completion

    During the period 8/11/23 through 8/11/24, registered participants wishing to receive continuing education credit for this activity must follow these steps:
    1. Read the learning objectives and faculty disclosures.
    2. Answer a pre-program question.
    3. View the program.
    4. Complete the post-test with a score of 100%. 
    5. Complete activity evaluation.
    6. Apply for credit and either bank your credits or print your certificate.

    For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule20 Jul 2024